Get Started

GERN

NASD Geron Corporation
Nov 10, 2026 · 6:41 PM ET LAST TRADE Market Closed

$0.9801 ↑ +0.0059 (+0.61%) Trading Up from the previous close of $0.9742, $0.0449 below the day’s high of $1.0250

YTD change
-25.75%
vs 20-day SMA
-9.35%
vs 200-day SMA
-30.71%

Price ranges

Previous day
$0.9739 $1.0000
open $0.9929 close $0.9965
+$0.0036 (+0.36%)
Today
$0.9412 $1.0250
open $0.9857 now $0.9801
-$0.0056 (-0.57%)
Past week
$0.9232 $1.0900
from $0.9291 now $0.9801
+$0.0510 (+5.49%)
Past month
$0.8400 $1.2400
from $1.2200 now $0.9801
-$0.2399 (-19.66%)
This year
$0.8400 $2.0100
from $1.3200 now $0.9801
-$0.3399 (-25.75%)

Price & Performance

-0.39 (-28.31%) / 6M

$0.8356$1.12$1.40$1.69May 11Aug 11Nov 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 98.7% away from all-time highs of $75.8800
  • GERN is down 26% since the beginning of the year
  • GERN is down 16% over the past 12 months
  • GERN is down 20% over the past 1 month

GERN reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -14.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.02
Earnings momentum +21.0% Quarterly EPS growth
Quarterly change +21.0%

Valuation

P/E ratio N/A
Enterprise value $832.6M
Beta 0.79

Balance sheet & scale

IncomeN/A
Revenue$164.4M
Cash$389.9M
Debt$249.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $625.3M

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $919.96 +1.73%
IQV IQVIA Holdings Inc $278.84 +2.58%
CRL Charles River Laboratories International, Inc. $353.34 +4.69%
ICLR ICON Plc $207.59 +1.39%
IT Gartner, Inc. $191.02 +0.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.